GC and pulmonary arterial hypertension: In addition, cGMP regulates many biological processes [20], and GC inhibitors and activators (e.g., Nesiritide, Sildenafil, Riociguat) have been developed as pharmaceutical therapies for pulmonary hypertension, cardiovascular diseases, angina pectoris or erectile dysfunction [47,48].